Estradiol decanoate: Difference between revisions
Appearance
Content deleted Content added
←Created page with '{{Drugbox | Verifiedfields = | Watchedfields = | verifiedrevid = | IUPAC_name = [(8R,9S,13S,14S,17S)-3-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocy...' |
(No difference)
|
Revision as of 05:16, 18 December 2016
Clinical data | |
---|---|
Other names | E2D; Estradiol decylate; Estradiol 17β-decanoate; Estra-1,3,5(10)-triene-3,17β-diol 17β-decanoate |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C28H42O3 |
Molar mass | 426.641 g/mol g·mol−1 |
3D model (JSmol) | |
| |
|
Estradiol decanoate (E2D), or estradiol decylate, also known as estradiol 17β-decanoate or as estra-1,3,5(10)-triene-3,17β-diol 17β-decanoate, is a synthetic, steroidal estrogen and an estrogen ester – specifically, the 17β-decanoate diester of estradiol – which has been studied for use in hormone replacement therapy for ovariectomized women but was never marketed.[1][2]
See also
References
- ^ Luisi M, Kicovic PM, Alicicco E, Franchi F (1978). "Effects of estradiol decanoate in ovariectomized women". J. Endocrinol. Invest. 1 (2): 101–6. doi:10.1007/BF03350355. PMID 755846.
- ^ Ranjit Roy Chaudhury (1 January 1981). Pharmacology of Estrogens. Elsevier Science & Technology Books. p. 36. ISBN 978-0-08-026869-9.